|
PROCYTE LAUNCHES PINK RIBBON BREAST CANCER AWARENESS
CAMPAIGN
Encourages Women to Talk about Health Issues and Skin Care
Redmond, Wash.—September 28, 2004—ProCyte Corporation (OTCBB: PRCY.OB), a company that develops and markets skin
care and procedure related products for the dermatology, cosmetic
surgery and spa markets today announced a promotion supporting breast cancer awareness and
wellness during October’s 20th Anniversary of National Breast
Cancer Awareness Month.
As part of this promotion, ProCyte Corporation is introducing a special edition Pink Ribbon
Neova® Herbal Wash to its physician customers and a portion
of the product proceeds will be donated to breast cancer research
initiatives. Herbal Wash, a soap free, refreshing botanical cleanser is
the Company’s most popular skin cleanser and appeals to women of all
ages. The attractively packaged product is perfect for travel, as a
gift or as a show of support for a friend touched by breast cancer.
Statistics
predict that in 2004 alone 216,000 American women will be diagnosed with
breast cancer (Susan G. Komen Foundation, 2004). The Pink Ribbon Neova®
Herbal Wash Promotion is intended to persuade women to talk to their
mothers, sisters and friends in spreading the word about breast cancer
awareness and open them up to discussing additional personal issues such
as health care and skin health.
“Breast Cancer is
a disease that has or will impact everyone in some aspect of their
lives. ProCyte provides physicians with Complex Cu3®
post-procedure products for use following procedures such as breast
reconstructive surgery and biopsies as well as for use after cosmetic
procedures,” explains Jack Clifford, President & CEO.
ProCyte products
are sold by leading dermatologists, cosmetic surgeons and through the
Internet via physician-related websites such as www.dermadoctor.com,
www.agelessinseattle.com, and www.skincarerx.com as well as others.
ProCyte Corporation
develops and markets products based on its patented, clinically proven
GHK and AHK Copper Peptide technology for skin health, hair care and
wound care. The Company sells directly to dermatologists, plastic and
cosmetic surgeons, spas and salons and through licenses with strategic
partners into the consumer market, including its long-term worldwide
license agreement with Neutrogena®, a Johnson and Johnson
company (NYSE: JNJ). ProCyte brands include Neova®,
VitalCopper™,
NextDerm™, Simple Solutions®
and AquaSanté®
Skin Care products; Complex Cu3®,
GraftCyte®
and Tricomin®.
Additional information is available by visiting the Company’s website at
www.procyte.com.
###
This release may contain forward-looking statements relating to the
research, development, commercialization, production, marketing and
distribution of the Company's products and future operating results,
which are subject to certain risks and uncertainties that could cause
actual results to differ materially from those projected.
The
words “believe,” “expect,” “intend,” “anticipate,” variations of such
words, and similar expressions
identify forward-looking statements, but their absence does not mean
that the statement is not forward-looking. These statements are not
guarantees of future performance and are subject to certain risks,
uncertainties and assumptions that are difficult to predict. Factors
that could affect the Company’s actual results include its ability to
develop, commercialize and produce new products; the market acceptance
of existing and potential future products; the availability, cost and
timely delivery of materials and services from and performance of
third-party suppliers, manufacturers, distributors, licensees and other
collaborative partners; the satisfaction of regulatory requirements, and
the receipt, timing, terms and conditions of required regulatory
approvals. Reference is made to the Company’s Annual Report on Form
10-K for the year ended December 31, 2003 and its latest quarterly
report on Form 10Q filed with the Securities and Exchange Commission for
a more detailed description of such factors. Readers are cautioned not
to place undue reliance on these forward-looking statements, which speak
only as of the date of this release. The Company undertakes no
obligation to publicly update any forward-looking statement to reflect
new information, events or circumstances after the date of this release
or to reflect the occurrence of unanticipated events.
|
